Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
http://dspace.nuph.edu.ua/handle/123456789/28207
Полная запись метаданных
Поле DC | Значение | Язык |
---|---|---|
dc.contributor.author | Benzid Yassine | - |
dc.contributor.author | Kaddi Kaoutar | - |
dc.contributor.author | Seniuk, I. V. | - |
dc.date.accessioned | 2022-06-11T18:19:51Z | - |
dc.date.available | 2022-06-11T18:19:51Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Benzid Yassine. COVID-19 and the cardiovascular system / Benzid Yassine, Kaddi Kaoutar, I. V. Seniuk // Фітофармакологія нирок, печінки та обміну речовин : матеріали міжнар. наук.-практ. конф., м. Харків, 19-20 трав. 2022 р. - Харків, НФаУ, 2022. - С. 49-52. | uk_UA |
dc.identifier.uri | http://dspace.nuph.edu.ua/handle/123456789/28207 | - |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)- related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascular system. Therefore, particular attention should be given to cardiovascular protection during treatment for COVID-19. In December 2019, an outbreak of pneumonia caused by a novel coronavirus occurred in Wuhan, Hubei province, and has spread rapidly throughout China, with an ongoing risk of a pandemic [1]. After virus identification and isolation, the pathogen for this pneumonia was originally called 2019 novel coronavirus [2] but has subsequently been officially named severe acute respiratory syndrome coronavirus 2 by the WHO. On 30 January 2020, the WHO declared the outbreak of SARS-CoV-2 a Public Health Emergency of International Concern. Compared with the SARS-CoV that caused an outbreak of SARS in 2003, SARS-CoV-2 has a stronger transmission capacity. The rapid increase in confirmed cases makes the prevention and control of COVID-19 extremely serious. Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients have severe cardiovascular damage [3]. In addition, some patients with underlying cardiovascular diseases (CVDs) might have an increased risk of death [3]. Therefore, understanding the damage caused by SARS-CoV-2 to the cardiovascular system and the underlying mechanisms is of the greatest importance, so that treatment of these patients can be timely and effective and mortality reduced. | uk_UA |
dc.language.iso | ru | uk_UA |
dc.subject | COVID-19 | uk_UA |
dc.subject | the cardiovascular system | uk_UA |
dc.title | COVID-19 and the cardiovascular system | uk_UA |
dc.type | Article | uk_UA |
Располагается в коллекциях: | Тези доповідей співробітників НФаУ |
Файлы этого ресурса:
Файл | Описание | Размер | Формат | |
---|---|---|---|---|
49-52.pdf | 549,02 kB | Adobe PDF | Просмотреть/Открыть |
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.